Centene Corporation
CNC Healthcare Healthcare Plans
Centene Corporation’s revenue for fiscal 2025 (year ended December 2025) was $194.8 billion, up 19.4% from fiscal 2024. In the quarter to June 2026, revenue grew 9.92%, EPS grew 533.3%, free cash flow grew 116.6% and total debt fell 8.37%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years.
Follow CNC
Centene Corporation (CNC) P/E ratio
Centene Corporation has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 67.2× (December 2021) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 9.7× | (38.00%) |
| FY2023 | 15.6× | (59.35%) |
| FY2022 | 38.3× | 7.47% |
| FY2021 | 35.7× | 85.40% |
| FY2020 | 19.2× | (2.38%) |
| FY2019 | 19.7× | (18.98%) |
| FY2018 | 24.3× | 13.80% |
| FY2017 | 21.4× | 18.38% |
| FY2016 | 18.1× | (18.25%) |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 42 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| CLOV Clover Health Investments, Corp. compare | n/m |
| MOH Molina Healthcare, Inc compare | n/m |
| CNC Centene Corporation | n/m |
| CI Cigna Group compare | 12.5× |
| OSCR Oscar Health, Inc. compare | 18.6× |
| ELV Elevance Health, Inc. compare | 19.0× |
| CVS CVS Health Corporation compare | 24.1× |
| UNH UnitedHealth Group Incorporated compare | 25.8× |
| HUM Humana Inc. compare | 38.8× |
| Healthcare Plans industry median | 25.0× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on CNC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement